These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 1357554

  • 1. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW.
    N Engl J Med; 1992 Nov 12; 327(20):1420-5. PubMed ID: 1357554
    [Abstract] [Full Text] [Related]

  • 2. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS.
    Ann Allergy Asthma Immunol; 1995 Aug 12; 75(2):180-4. PubMed ID: 7648385
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 12; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.
    Ann Allergy Asthma Immunol; 1997 May 11; 78(5):457-64. PubMed ID: 9164358
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.
    Am J Manag Care; 1998 Nov 22; 4(11):1579-87. PubMed ID: 10338904
    [Abstract] [Full Text] [Related]

  • 10. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G, Williams DA, Weller P, Price JF.
    Ann Allergy Asthma Immunol; 1995 Nov 22; 75(5):423-8. PubMed ID: 7583864
    [Abstract] [Full Text] [Related]

  • 11. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE.
    N Engl J Med; 1997 Dec 04; 337(23):1659-65. PubMed ID: 9385125
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM, Anderson TJ, Parashchak MR, Burke CM, Watson SA, Turbitt ML.
    Respir Med; 1999 Jul 04; 93(7):236-44. PubMed ID: 10464829
    [Abstract] [Full Text] [Related]

  • 13. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 04; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ, Kraft M, Beaucher WN, Kiechel F, Sublett JL, LaVallee N, Shilstone J.
    Ann Allergy Asthma Immunol; 1999 Aug 04; 83(2):121-6. PubMed ID: 10480584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K.
    Ann Allergy Asthma Immunol; 1998 Jun 04; 80(6):463-70. PubMed ID: 9647268
    [Abstract] [Full Text] [Related]

  • 18. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
    Wolfe J, Kreitzer S, Chervinsky P, Lawrence M, Wang Y, Reilly D, Davis S, Stahl E.
    Ann Allergy Asthma Immunol; 2000 Mar 04; 84(3):334-40. PubMed ID: 10752919
    [Abstract] [Full Text] [Related]

  • 19. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar 04; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.